On-demand education
Filter
FILTER BY TESTS
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Barrett’s Esophagus Panel: Predicting Progression in Barrett’s Esophagus Recent Advances Webinar

A panel discussion on the clinical challenges associated with predicting progression to esophageal adenocarcinoma in patients with Barrett’s esophagus.
TissueCypher
Barrett's Esophagus
Authors: Sri Komanduri, MD, FASGE, AGAF Director of Endoscopy Northwestern University, David Diehl, MD, FACP, FASGE Director of Interventional Endoscopy Geisinger Health System, Prasad G. Iyer, MD, MS, FASGE, FACG, Gastroenterologist, Mayo Clinic,
Prognostic
Gastroenterology
Webinar

DermPath on Demand: Utility of Gene Expression Profiling in Melanocytic Lesions

MyPath Melanoma
DiffDx-Melanoma
Cutaneous Melanoma
Authors: Clay Cockerell, M.D.
Diagnostic
Dermatology

Comprehensive Diagnostic Offering – Highly Accurate and Objective Tests for Melanocytic Lesions of Uncertain Potential

MyPath Melanoma
DiffDx-Melanoma
Authors: Matthew Goldberg, MD
Diagnostic
Dermatology

Castle Biosciences Genomic Testing for Uveal Melanoma

DecisionDx-UM
Authors: Katherina Alsina, PhD
Prognostic
Ophthalmology

Updates in Screening and Surveillance for Barrett’s Esophagus

We have become excellent at treating Barrett’s esophagus (BE) related neoplasia. But to reduce the instance of esophageal adenocarcinoma (EAC) we need to increase the population under surveillance and leverage risk stratification tools to personalize the management of non-dysplastic BE.
TissueCypher
Barrett's Esophagus
Authors: Sri Komanduri, MD, FASGE, AGAF Director of Endoscopy Northwestern University
Prognostic
Gastroenterology
Webinar

Integrating new technology into the management of non-dysplastic Barrett’s esophagus patients

No items found.
Authors: Lipham J, Muthusamy R, Khara H

Prediction of Progression in Barrett’s Esophagus Using a Tissue Systems Pathology Test: A Pooled Analysis of International Multicenter Studies

Clinical Gastroenterolgy and Hepatology 2022
TissueCypher
Barrett's Esophagus
Authors: Iyer PG, Codipilly DC, Chandar AK, Agarwal S, Wang KK, Leggett CL, Latuche LR, Schulte PJ
Prognostic
Gastroenterology
Publication

Imported item 2

No items found.
Authors:

Barrett’s Esophagus Panel: Establishing Individual Patient Risk for Progression to Esophageal Cancer

Understand how TissueCypher® predicts future development of HGD/EAC in patients with BE. Impacts patient-care decisions as demonstrated by case studies.
TissueCypher
Barrett's Esophagus
Authors: Sri Komanduri, MD, FASGE, AGAF Director of Endoscopy Northwestern University. Rhonda Souza, MD,Co-Director, Baylor Scott & White Health, Vani Konda, MD Medical Director Baylor Scott & White Health
Prognostic
Gastroenterology
Webinar

Risk Stratification and Management of Dysplastic Barrett’s Esophagus*

Risk stratification is important in managing BE patients and biomarker assays such as TissueCypher® are “ready for Prime Time” in identifying patients at high risk for progression.
TissueCypher
Barrett's Esophagus
Authors:
Prognostic
Gastroenterology
Webinar

AHNS DecisionDx–SCC Webinar: Identifying the Risk of Metastasis in cSCC and cSCC-HN Patients

DecisionDx-SCC
Cutaneous Squamous Cell Carcinoma
Authors: Jason Newman, MD, FACS
Prognostic
Dermatology
Video

Maui Derm DecisionDx-SCC Product Theater: Identifying the Risk of Metastasis in cSCC Patients with One or More Risk Factors.

DecisionDx-SCC
Cutaneous Squamous Cell Carcinoma
Authors: Brent Moody, MD, FACP, FAAD
Prognostic
Dermatology
Video